Cargando…
Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics Testing
As recognised by the National Institutes of Health (NIH) Precision Medicine Initiative (PMI), microarray technology currently provides a rapid, inexpensive means of identifying large numbers of known genomic variants or gene transcripts in experimental and clinical settings. However new generation s...
Autores principales: | Shahandeh, Al, Johnstone, Daniel M., Atkins, Joshua R., Sontag, Jean-Marie, Heidari, Moones, Daneshi, Nilofar, Freeman-Acquah, Elvis, Milward, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003488/ https://www.ncbi.nlm.nih.gov/pubmed/27600079 http://dx.doi.org/10.3390/microarrays5020012 |
Ejemplares similares
-
Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multi-Center Pilot for Pre-Emptive Pharmacogenomics in Electronic Health Record Systems
por: Rasmussen-Torvik, Laura J., et al.
Publicado: (2014) -
Regional blocks for pre-emptive anti-emesis
por: Gupta, Deepak
Publicado: (2012) -
Pre-emptive genomic surveillance of emerging ebolaviruses
por: Postigo-Hidalgo, Ignacio, et al.
Publicado: (2020) -
Adding pre-emptive anticholinergics to antipsychotics: Is it justified?
por: Chatterjee, Kaushik, et al.
Publicado: (2022) -
Pre emptive analgesia for reducing pain after cholecystectomy: Oral tramadol vs. acetaminophen codeine
por: Zavareh, Sayyed Morteza Heidari Tabaei, et al.
Publicado: (2013)